Parallel Advisors, LLC - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 206 filers reported holding BEAM THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.17 and the average weighting 0.3%.

Quarter-by-quarter ownership
Parallel Advisors, LLC ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$7,528
+1714.0%
313
+2307.7%
0.00%
Q2 2023$415
-76.2%
13
-77.2%
0.00%
Q1 2023$1,745
-89.7%
57
-86.8%
0.00%
-100.0%
Q4 2022$16,935
+746.8%
433
+1039.5%
0.00%
Q3 2022$2,000
+100.0%
38
+58.3%
0.00%
Q2 2022$1,000
-66.7%
24
-46.7%
0.00%
Q1 2022$3,000
-66.7%
45
-57.9%
0.00%
Q4 2021$9,000
+350.0%
107
+463.2%
0.00%
Q3 2021$2,000
+100.0%
19
+90.0%
0.00%
Q2 2021$1,0000.0%100.0%0.00%
Q1 2021$1,0000.0%100.0%0.00%
Q4 2020$1,000100.00%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
MWG Management Ltd. 2,362,635$205,573,00024.93%
HSG Holding Ltd 796,089$69,268,0006.22%
DC Investments Management, LLC 21,010$1,828,0003.41%
Redmile Group, LLC 1,975,006$171,845,0003.00%
Casdin Capital, LLC 818,820$71,246,0001.77%
Evolutionary Tree Capital Management, LLC 44,390$3,862,0001.71%
HHLR ADVISORS, LTD. 1,448,161$126,004,0001.65%
Nan Fung Group Holdings Ltd 54,903$4,777,0001.53%
ARK Investment Management 6,841,722$595,298,0001.43%
BRANDYWINE MANAGERS, LLC 12,900$1,122,0001.17%
View complete list of BEAM THERAPEUTICS INC shareholders